BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32562805)

  • 21. Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain.
    Gdowski AS; Ranjan A; Sarker MR; Vishwanatha JK
    Nanomedicine (Lond); 2017 Sep; 12(17):2083-2095. PubMed ID: 28805551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells.
    Mukhtar E; Adhami VM; Siddiqui IA; Verma AK; Mukhtar H
    Mol Cancer Ther; 2016 Dec; 15(12):2863-2874. PubMed ID: 27765854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cabazitaxel for the treatment of prostate cancer.
    Michielsen DP; Braeckman JG; Denis L
    Expert Opin Pharmacother; 2011 Apr; 12(6):977-82. PubMed ID: 21406025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testosterone Diminishes Cabazitaxel Efficacy and Intratumoral Accumulation in a Prostate Cancer Xenograft Model.
    Mout L; de Wit R; Stuurman D; Verhoef E; Mathijssen R; de Ridder C; Lolkema M; van Weerden W
    EBioMedicine; 2018 Jan; 27():182-186. PubMed ID: 29276148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial.
    Beer TM; Hotte SJ; Saad F; Alekseev B; Matveev V; Fléchon A; Gravis G; Joly F; Chi KN; Malik Z; Blumenstein B; Stewart PS; Jacobs CA; Fizazi K
    Lancet Oncol; 2017 Nov; 18(11):1532-1542. PubMed ID: 29033099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical evaluation of taxane-binding peptide-modified polymeric micelles loaded with docetaxel in an orthotopic breast cancer mouse model.
    Logie J; Ganesh AN; Aman AM; Al-Awar RS; Shoichet MS
    Biomaterials; 2017 Apr; 123():39-47. PubMed ID: 28161682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-assembled Micelle Loading Cabazitaxel for therapy of Lung Cancer.
    Zhuang B; Du L; Xu H; Xu X; Wang C; Fan Y; Cong M; Yin J; Li H; Guan H
    Int J Pharm; 2016 Feb; 499(1-2):146-155. PubMed ID: 26762884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and in vitro evaluation of a pH-sensitive PLA-PEG-folate based polymeric micelle for controlled delivery of docetaxel.
    Hami Z; Amini M; Ghazi-Khansari M; Rezayat SM; Gilani K
    Colloids Surf B Biointerfaces; 2014 Apr; 116():309-17. PubMed ID: 24503352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA.
    Kang Y; Lu L; Lan J; Ding Y; Yang J; Zhang Y; Zhao Y; Zhang T; Ho RJY
    Acta Biomater; 2018 Mar; 68():137-153. PubMed ID: 29288085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymeric Micellar Delivery of Novel Microtubule Destabilizer and Hedgehog Signaling Inhibitor for Treating Chemoresistant Prostate Cancer.
    Yang R; Chen H; Guo D; Dong Y; Miller DD; Li W; Mahato RI
    J Pharmacol Exp Ther; 2019 Sep; 370(3):864-875. PubMed ID: 30996033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release.
    Xu M; Zhang CY; Wu J; Zhou H; Bai R; Shen Z; Deng F; Liu Y; Liu J
    ACS Appl Mater Interfaces; 2019 Feb; 11(6):5701-5713. PubMed ID: 30644711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IDO-triggered swellable polymeric micelles for IDO inhibition and targeted cancer immunotherapy.
    Park J; Nah Y; Kim WJ
    J Control Release; 2023 Nov; 363():496-506. PubMed ID: 37788761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trial.
    Corn PG; Heath EI; Zurita A; Ramesh N; Xiao L; Sei E; Li-Ning-Tapia E; Tu SM; Subudhi SK; Wang J; Wang X; Efstathiou E; Thompson TC; Troncoso P; Navin N; Logothetis CJ; Aparicio AM
    Lancet Oncol; 2019 Oct; 20(10):1432-1443. PubMed ID: 31515154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
    Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel pH-triggered biocompatible polymeric micelles based on heparin-α-tocopherol conjugate for intracellular delivery of docetaxel in breast cancer.
    Emami J; Kazemi M; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A
    Pharm Dev Technol; 2020 Apr; 25(4):492-509. PubMed ID: 31903817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermo-responsive release of curcumin from micelles prepared by self-assembly of amphiphilic P(NIPAAm-co-DMAAm)-b-PLLA-b-P(NIPAAm-co-DMAAm) triblock copolymers.
    Hu Y; Darcos V; Monge S; Li S; Zhou Y; Su F
    Int J Pharm; 2014 Dec; 476(1-2):31-40. PubMed ID: 25260217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation.
    de Morrée E; van Soest R; Aghai A; de Ridder C; de Bruijn P; Ghobadi Moghaddam-Helmantel I; Burger H; Mathijssen R; Wiemer E; de Wit R; van Weerden W
    Prostate; 2016 Jul; 76(10):927-36. PubMed ID: 26997363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current development of cabazitaxel drug delivery systems.
    Sun B; Lovell JF; Zhang Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1854. PubMed ID: 36161272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, characterization, and in vitro evaluation of TRAIL-modified, cabazitaxel -loaded polymeric micelles for achieving synergistic anticancer therapy.
    Feng C; Han X; Chi L; Sun J; Gong F; Shen Y
    J Biomater Sci Polym Ed; 2018 Oct; 29(14):1729-1744. PubMed ID: 29851539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redox-responsive star-shaped magnetic micelles with active-targeted and magnetic-guided functions for cancer therapy.
    Tang Z; Zhang L; Wang Y; Li D; Zhong Z; Zhou S
    Acta Biomater; 2016 Sep; 42():232-246. PubMed ID: 27373437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.